Search Prime Contracts

140D0426C0123

Definitive Contract

Overview

Government Description
ARPA-H Snc Quiet STTR Phase II
Place of Performance
Evanston, IL 60201 United States
Pricing
Fixed Price
Set Aside
Small Business Set Aside - Total (SBA)
Extent Competed
Full And Open Competition After Exclusion Of Sources
Research Type
Small Business Innovation Research Program (SBIR) Phase II
Est. Average FTE
8
Related Opportunity
None
SNC Therapeutics was awarded Definitive Contract 140D0426C0123 (140D04-26-C-0123) for Arpa-H Snc Quiet Sttr Phase Ii worth up to $3,499,423 by the National Institutes of Health in September 2026. The contract has a duration of 2 years and was awarded with a Small Business Total set aside with NAICS 541715 and PSC AN13 via direct negotiation acquisition procedures with 2 bids received.

Status
(Open)

Last Modified 9/30/26
Period of Performance
9/24/26
Start Date
9/27/28
Current End Date
9/27/28
Potential End Date
7.0% Complete

Obligations
$3.5M
Total Obligated
$3.5M
Current Award
$3.5M
Potential Award
100% Funded

Award Hierarchy

Definitive Contract

140D0426C0123

Subcontracts

0

Activity Timeline

Interactive chart of timeline of amendments to 140D0426C0123

Transaction History

Modifications to 140D0426C0123

People

Suggested agency contacts for 140D0426C0123

Competition

Number of Bidders
2
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
YNQPL17KGWA6
Awardee CAGE
253M3
Agency Detail
Awarding Office
140D04 IBC ACQ SVCS DIRECTORATE (00004)
Funding Office
75N992
Created By
decarloj
Last Modified By
jkunkle
Approved By
jkunkle

Legislative

Legislative Mandates
None Applicable
Performance District
IL-09
Senators
Richard Durbin
Tammy Duckworth
Representative
Janice Schakowsky
Modified: 9/30/26